Richard Schilling, DPM
Podiatrist · Columbus, OHNPI 1245238849
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 47 manufacturers reported payments, led by Kerecis Limited at 37.3% of the total. Reporting peaked in 2024 at $8,238 and has fallen 87.4% since, to $1,037 in 2025. Among podiatrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 298 payments — averaging $68.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$8K
- Alfasigma USA, Inc.$3K
- Triad Life Sciences Inc.$2K
- Smith+Nephew$1K
- Amgen$693
- Paratek Pharmaceuticals, Inc.$641
- plus $4K from 41 others
Across 17 payments — averaging $3012.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Royal Biologics, Inc.$27K
- Kerecis Limited$24K
What the payments were for
- Consulting fees$11,02554%
- Travel & lodging$2,53512%
- Food & beverage$6,88934%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$30,200
- Kerecis Omega3 SurgiClose$7,550
- InnovaMatrix AC$2,136
- Lapiplasty System$521
- RAYOS$331
- Senza$235
- KRYSTEXXA$230
- QUANTUM$125
- PROSTEP MICA$117
- PuraPly$108
- ANJESO$100
How this compares
$20,449 in reported general payments places this provider in the 95th percentile of 397 podiatrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 78 | $1,816 |
| Gabapentin | 45 | $869 |
| Duloxetine Hcl | 31 | $747 |
| CiclopiroxCiclopirox Olamine | 44 | $505 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $260 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $225 |
| Methylprednisolone | 26 | $167 |
| Doxycycline Hyclate | 12 | $107 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Columbus
- Joseph BrownColumbus$11K
- David KaplanskyColumbus$9K
- Donnalyn MoellerColumbus$9K
- Anthony CozzolinoColumbus$6K
- Mark HardyAvon$2.1M
- Lawrence DidomenicoBoardman$1.1M
- Ralph NapolitanoNew Albany$494K
- Thomas GronerNiles$193K
- Michael MaierCleveland$120K
- Eric StortsLondon$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.